Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
19,667,509
-
Number of holders
-
248
-
Total 13F shares, excl. options
-
22,870,335
-
Shares change
-
+791,099
-
Total reported value, excl. options
-
$2,179,670,768
-
Value change
-
+$68,808,132
-
Put/Call ratio
-
1048%
-
Number of buys
-
116
-
Number of sells
-
134
-
Price
-
$95.32
Institutional Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q3 2020
As of 30 Sep 2020 LIGAND PHARMACEUTICALS INC - Common Stock (LGND) had 248 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 22,870,335 shares of stock of the company.
Largest 10 holders included BlackRock Inc., WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, WASATCH ADVISORS INC, STATE STREET CORP, CARDINAL CAPITAL MANAGEMENT LLC /CT, MACQUARIE GROUP LTD, Conestoga Capital Advisors, LLC, and VILLERE ST DENIS J & CO LLC.
This table shows 248 institutional shareholders of the security as of 30 Sep 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.